Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis to appeal Zelnorm rejection

January 18, 2006
Sales and Marketing

Novartis says it will appeal against an EMEA decision not to recommend its irritable bowel syndrome drug Zelnorm. Zelnorm (tegaserod) …

News

Prescribers ready to defy NICE in Alzheimer’s drug row

January 18, 2006
Sales and Marketing

Patient groups and manufacturers are hoping NICE will reverse its decision to deny access to Alzheimer's drugs on the NHS, …

News

First-in-class indication expected for Remicade

January 18, 2006
Sales and Marketing

Schering-Plough expects its arthritis treatment Remicade to receive European approval to treat ulcerative colitis in early 2006.If approved Remicade (infliximab) …

News

StayinFront wins Roche regional contract

January 18, 2006
Business Services

Roche will equip its Central and Eastern European salesforces with StayinFront customer relationship management software after expanding its current contract …

News

Patient-led NHS revolution to continue, says under fire Hewitt

January 18, 2006

Patricia Hewitt has pledged to press ahead with the next phase of Labour's NHS reforms, despite renewed opposition from within …

News

Merck in race to bring first cervical cancer vaccine to market

January 18, 2006
Sales and Marketing

Merck and GlaxoSmithKline are head-to-head in a race to establish a market for their rival cervical cancer vaccines, both set …

News

Drinking straw a novel antibiotic delivery for children

January 17, 2006
Sales and Marketing

A new drinking straw that administers antibiotics to children as they drink has been launched by German pharma company Grunenthal.Clarosip …

News

Virgo Health wins Cymbalta account

January 17, 2006
Medical Communications

Virgo Health has been appointed to promote depression brand Cymbalta to healthcare professionals in the UK following a two-way competitive …

News

Right time, right place, right patient

January 17, 2006
Research and Development

With patient recruitment such a key cog in the overall clinical trial machine, pharma and biotech businesses are increasing their …

Feature

Pfizer to go it alone with Exubera

January 16, 2006
Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin

 Pfizer has paid $1.3 billion to buy out its marketing partner’s stake in new inhaled diabetes drug Exubera.The US company …

News

Gene discovery offers new diabetes drug target hope

January 16, 2006
Research and Development

A gene thought to be present in around 20% of type II diabetes patients has been identified, opening up the …

News

Unfamiliar territory

January 13, 2006

At this year's NHS Confederation conference in June, the most debated corridor question was whether or not there would be …

Feature

Patients unaware as flagship NHS choice scheme launched

January 12, 2006

Primary Care Trusts across England have launched an unprecedented marketing campaign to promote the new NHS choice agenda to patients.From …

News

Packer Forbes wins Remicade and Altana accounts

January 12, 2006
Medical Communications

Packer Forbes has won new accounts from Schering-Plough for the arthritis treatment Remicade and from Altana Pharma for the company's …

News

Bayer buys hypertension drug rights from GSK

January 12, 2006
Sales and Marketing

Bayer has bought the rights to market the hypertension drug telmisartan in a number of European markets from current licence …

News

Action needed on prostate cancer services

January 12, 2006

Patients with prostate cancer are a lower NHS priority than those with other major cancers, despite the disease's status as …

News

PCT merger plans ‘ill conceived’

January 12, 2006

Government plans for a radical restructuring of the NHS have been condemned in a new report by a committee of …

News

New dawn or beginning of the end? Medicare D comes of age

January 12, 2006
Sales and Marketing

Millions of Americans woke up on 1 January 2006 and found themselves in an unfamiliar position  having their prescription medicine …

News

GlaxoSmithKline considering Serono acquisition

January 12, 2006
Sales and Marketing

GlaxoSmithKline is understood to be considering the acquisition of Europe's biggest biotech company Serono, currently worth around $12 billion.Serono's chief …

News

Wanted: Innovative drugs

January 12, 2006
Research and Development prix galien

When the UK government last month announced a series of measures to boost research and development in the NHS, its …

Feature
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026